Assessing the efficacy and safety of Yinqiao powder-maxing Ganshi decoction in the treatment of the major symptoms of mild and moderate COVID-19 by telemedicine–study protocol for a randomized, double-blind, placebo-controlled trial

Assessing the efficacy and safety of Yinqiao powder-maxing Ganshi decoction in the treatment of the major symptoms of mild and moderate COVID-19 by telemedicine–study protocol for a randomized, double-blind, placebo-controlled trial

Background: The Coronavirus disease 2019 (COVID-19) is the largest global epidemic in recent time. Chinese medicine has been recognized by the World Health Organization as an effective treatment for COVID-19, but there is still a lack of high-quality randomized, double-blind trials using placebo as...

Full description

Bibliographic Details
Main Authors: Chi Him Sum, Tong Wendy Li, Hongwei Zhang, Hing Yu Hung, Ben Yuk Fai Fong, Wai Ling Lin, Tak Yee Chow, Ka Chun Leung, Cho Wing Lo, Chon Pin Chia, Kam Leung Chan, Zhi-xiu Lin
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Pharmacology
Subjects:
COVID-19
Chinese medicine
Yinqiao Powder
Maxing Ganshi decoction
randomized control trial
clinical trial
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1261338/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1261338/full

Similar Items